Skip to content

Effect of long-term acupoint application on the regulation of persistent inflammation in allergic rhinitis:a randomized controlled preliminary study

Special research project of traditional Chinese medicine science and technology in Guangdong Provincial Hospital of Chinese Medicine

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2200006053
Enrollment
Unknown
Registered
2022-06-03
Start date
2022-05-23
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

allergic rhinitis(AR)

Interventions

treatment group:Acupoint herbal patching
control group:placebo application

Sponsors

Guangdong Provincial Hospital of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1) Meet the Chinese and western diagnostic criteria of AR, Chinese Medicine syndrome differentiation is deficiency syndrome (Lung, Spleen or Kidney deficiency, two or more aforementioned organs dificiency). 2) 18 to 65 years old, no gender limited. 3) Participants need informed consent and volunteer to participate the study. 4) Be able to complete relevant records such as case report form and cooperate with follow-up and / or waiting as required.

Exclusion criteria

Exclusion criteria: 1) Participants who have suffered rhinitis (cold), vasomotor rhinitis, autonomic rhinitis, eosinophilic non-allergic rhinitis, allergic sinusitis. 2) Participants who are allergic to adhesive tape. 3) Participants who have difficult to heal local skin lesions such as burns, eczema, ulcers and frostbite. 4) Pregnant women, if they are found to be pregnant during the study, suspend the test; women's menstruation is suspended (it can be subsidized after menstruation, but the date of application should be indicated). 5) Participants who can not fully cooperate with the experimenters and investigators,due to mental or behavioral disorders. 6) Participants who are easy to lose follow-up due to frequent changes in working environment and other reasons.

Design outcomes

Primary

MeasureTime frame
Total nasal symptom score;

Secondary

MeasureTime frame
Interleukin-33;Visual analogue scale;Interleukin-4;Interleukin-17;Eosinophil cationic protein;The standardized version of the Rhinoconjunctivitis Quality of Life Questionnaire;Interleukin-10;Interferon-?;Days of attack per week;

Countries

China

Contacts

Public ContactLuo Qiulan
13760713695@126.com+86 13760713695

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026